# 70436-203-80 · Dobutamine Hydrochloride Injection · Hainan Poly Pharm. Co., Ltd. — FDA drug shortage duration tracker

For 70436-203-80 · Dobutamine Hydrochloride Injection · Hainan Poly Pharm. Co., Ltd., package ndc is 70436-203-80; generic name is Dobutamine Hydrochloride Injection; manufacturer is Hainan Poly Pharm. Co., Ltd; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08.

- **Package NDC:** 70436-203-80 _(verified: appears in the quote below)_
- **Generic name:** Dobutamine Hydrochloride Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hainan Poly Pharm. Co., Ltd. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **FDA note:** Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988 _(verified: appears in the quote below)_
- **Initial posting date:** 11/06/2017 _(verified: appears in the quote below)_
- **Last update date:** 05/08/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3221 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Cardiovascular _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "11/06/2017", "package_ndc": "70436-203-80", "generic_name": "Dobutamine Hydrochloride Injection", "contact_info": "Slate Run Pharmaceuticals, LLC: 844-529-8988", "availability": "Available", "related_info": "Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "05/08/2026", "therapeutic_category": [ "Cardiovascular", "Pediatric", "Renal" ], "dosage_form": "Injection", "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)", "company_name": "Hainan Poly Pharm. Co., Ltd.", "status": "Current"

### Status

> "update_date": "05/08/2026", "therapeutic_category": [ "Cardiovascular", "Pediatric", "Renal" ], "dosage_form": "Injection", "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)", "company_name": "Hainan Poly Pharm. Co., Ltd.", "status": "Current"

### Last update date

> "update_date": "05/08/2026", "therapeutic_category": [ "Cardiovascular", "Pediatric", "Renal" ], "dosage_form": "Injection", "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)", "company_name": "Hainan Poly Pharm. Co., Ltd.", "status": "Current"

### Dosage form

> "update_date": "05/08/2026", "therapeutic_category": [ "Cardiovascular", "Pediatric", "Renal" ], "dosage_form": "Injection", "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)", "company_name": "Hainan Poly Pharm. Co., Ltd.", "status": "Current"

### Therapeutic category

> "update_date": "05/08/2026", "therapeutic_category": [ "Cardiovascular", "Pediatric", "Renal" ], "dosage_form": "Injection", "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)", "company_name": "Hainan Poly Pharm. Co., Ltd.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-08. Review by: 2026-09-11.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).